The optimal treatment for adults with newly diagnosed medulloblastoma (MB) has not been defined. We report a large series of cases from the Rare Cancer Network.
from Imaging via alkiviadis.1961 on Inoreader http://ift.tt/2mGWlIO
Πέμπτη 18 Ιανουαρίου 2018
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Related Articles Middle ear adenomatous neuroendocrine tumors: a 25-year experience at MD Anderson Cancer Center. Virchows Arch. 2017...
-
Abstract Background The role of thymectomy in the treatment of juvenile myasthenia gravis (JMG) is poorly defined. The objective of this...
-
Biomarker testing is recommended for all patients diagnosed with non–small cell lung cancer. At a minimum, testing should include the mutati...
-
American Thyroid Resarch Grant to Nikita Pozdeyev, MD, PhD, University of Colorado Newswise (press release) The 2016 Research Grant h...
-
A host of new therapies are now available for treating patients with chronic lymphocytic leukemia (CLL) in both the upfront and relapsed or ...
-
In the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer, among adjuvant radiotherapy options for whole-brea...
-
Need APA Citations? Stop wasting time hand-writing your bibliography, sign up for EasyBib Pro Now! Join EasyBib Pro Now from #AlexandrosSf...
-
To link to this poem, put the URL below into your page: <a href=http:///poems/>Song of Myself by Walt Whitman</a> Plain for Prin...
-
ACS Nano DOI: 10.1021/acsnano.7b01995 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2o1Fb7w via...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου